Short description
NewLink Genetics, a biopharmaceutical company, develops therapeutic and diagnostic agents for patients with cancer and infectious diseases.
Description
NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer.
Founded more than 15 years ago, NewLink Genetics continues to be at the forefront in immuno-oncology treatments led by a diverse group of industry professionals and physician-scientists. Personal cancer stories inspire their relentless research and development in advancing treatments. Their mission is to change the cancer treatment paradigm and make a difference in patient lives every day.
Last funding
Cannot Access
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Ames, Iowa, United States, North America
Founded on
January 1, 1999
Closed on
March 18, 2020
Exited on
November 14, 2011
Went public on
November 14, 2011
Delisted on
March 18, 2020
Stock symbol
NLNK
Non-profit?
No
Acquired?
No
Employees count
51-100
Investors
Blurry Noaccess, Absolutely Noaccess, Nopepepe, Noaccess, Noaccess
Sign in for full access
Founders
Charles Link, Nicholas Vahanian